CSHL Cancer Center

No. 474: On molecular diagnostics, robo-busts and T Rex – and happy birthday to the author of your youth

  Back stretch: Welcome to Wednesday, dear readers, and the clubhouse turn of our latest socioeconomic sprint. It’s Feb. 12 out there, replete with offbeat observations: choose from National Lost Penny Day, National Plum Pudding Day and Valentine’s Hug Day, a cuddly precursor to the big lovers’ day. They do: Speaking of lovers, it’s also a notable date for same-sex unions – National Freedom to Marry Day, which was actually started by a law firm…


In TD grant, big win for CSHL, Tuveson and society

By GREGORY ZELLER // A cutting-edge Cold Spring Harbor Laboratory cancer-detection science will get cutting-edgier, thanks to a stocking stuffer from TD Bank. New Jersey-based TD announced Tuesday more than $3 million in fresh grants, comprising the second funding round of its TD Ready Challenge, an application-based national competition designed to balance social scales while innovating early disease detection and intervention. Among them: a $750,000 award for CSHL aimed at advancing organoid-based clinical tests –…


Northwell takes cancer research to the biobank

By GREGORY ZELLER // A collaboration between New York’s largest healthcare system and a German oncology-research expert will look to customize cancer care to individual patient needs. New Hyde Park-based Northwell Health on Tuesday announced a new partnership with Indivumed GmbH, an International Organization for Standardization-certified R&D company based in Hamburg. The collaboration will focus on cancer-tissue “biospecimens” in an attempt to better understand cancer genetics – and ultimately create “individualized diagnostics and therapeutics,” Northwell…


Northwell/CSHL cancer center draws an ace

An internationally renowned cancer expert will help lead Northwell Health and Cold Spring Harbor Laboratory’s joint cancer-research initiative. Oncologist Robert Maki, known primarily as a leading sarcoma physician and researcher, will direct the Center for New Cancer Therapies at the Northwell Health Cancer Institute. The institute is a strategic affiliation between the New Hyde Park-based health system and CSHL, established in 2015 to accelerate cancer research and the development of new therapies. As director, Maki…


Stillman steps down as CSHL Cancer Center chief

By GREGORY ZELLER // After a quarter-century of heralded stewardship, Bruce Stillman is stepping away from his role as head of the Cold Spring Harbor Laboratory Cancer Center. Stillman was appointed Cancer Center director in 1992, succeeded CSHL icon James Watson as laboratory director in 1994 and was appointed president in 2003. He’ll still call the shots as CSHL’s president and CEO and will also continue his personal research into DNA replication and genome inheritance. But his…